An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection

被引：55

作者：

Ritter, MA ^{[1
]}

Furtek, CI ^{[1
]}

Lo, MW ^{[1
]}

机构：

[1] MERCK SHARP & DOHME LTD,RES LABS,DEPT DRUG METAB,W POINT,PA 19486

来源：

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 1997年 / 15卷 / 07期

关键词：

losartan; EXP3174; angiotensin II receptor antagonist; HPLC; fluorescence;

D O I：

10.1016/S0731-7085(96)01948-6

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

[No abstract available]

引用

页码：1021 / 1029

页数：9

共 8 条

[1] SIMULTANEOUS DETERMINATION OF A NOVEL ANGIOTENSIN-II RECEPTOR BLOCKING-AGENT, LOSARTAN, AND ITS METABOLITE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

FURTEK, CI ;

LO, MW .

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 573 (02) :295-301

[2] SAFETY AND TOLERABILITY OF LOSARTAN POTASSIUM, AND ANGIOTENSIN-II RECEPTOR ANTAGONIST, COMPARED WITH HYDROCHLOROTHIAZIDE, ATENOLOL, FELODIPINE ER, AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS FOR THE TREATMENT OF SYSTEMIC HYPERTENSION [J].

GOLDBERG, AI ;

DUNLAY, MC ;

SWEET, CS .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (12) :793-795

[3] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL STUDY OF VARIOUS DOSES OF LOSARTAN POTASSIUM COMPARED WITH ENALAPRIL MALEATE IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].

GRADMAN, AH ;

ARCURI, KE ;

GOLDBERG, AI ;

IKEDA, LS ;

NELSON, EB ;

SNAVELY, DB ;

SWEET, CS .

HYPERTENSION, 1995, 25 (06) :1345-1350

[4] Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans [J].

Lo, MW ;

Goldberg, MR ;

McCrea, JB ;

Lu, H ;

Furtek, CI ;

Bjornsson, TD .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (06) :641-649

[5] DRUG CONCENTRATION RESPONSE RELATIONSHIPS IN NORMAL VOLUNTEERS AFTER ORAL-ADMINISTRATION OF LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST [J].

MUNAFO, A ;

CHRISTEN, Y ;

NUSSBERGER, J ;

SHUM, LY ;

BORLAND, RM ;

LEE, RJ ;

WAEBER, B ;

BIOLLAZ, J ;

BRUNNER, HR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) :513-521

[6] BLOOD-PRESSURE EFFECTS OF THE ANGIOTENSIN-II RECEPTOR BLOCKER, LOSARTAN [J].

WEBER, MA ;

BYYNY, RL ;

PRATT, JH ;

FAISON, EP ;

SNAVELY, DB ;

GOLDBERG, AI ;

NELSON, EB .

ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (04) :405-411

[7] LOSARTAN (DUP 753), AN ORALLY ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST [J].

WONG, PC ;

BARNES, TB ;

CHIU, AT ;

CHRIST, DD ;

DUNCIA, JV ;

HERBLIN, WF ;

TIMMERMANS, PBMWM .

CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (04) :317-339

[8]

WONG PC, 1990, J PHARMACOL EXP THER, V255, P211

← 1 →